Safety and Efficacy of Carotid Angioplasty and Stenting in High-Risk Patients

Abstract

Performance of carotid endarterectomy (CEA) may be associated with an increased risk in patients with significant comorbid medical conditions, neck irradiation, or previous CEA. This study compared the results of CEA with carotid angioplasty and stenting (CAS) in high-risk patients treated for carotid stenosis. Five hundred forty-five patients who underwent CEA and 148 patients who underwent CAS were evaluated. For patients undergoing CEA, general anesthesia was used in 91 per cent, electroencephalographic monitoring was used in 63 per cent, and shunting was performed in 19.8 per cent. Cerebral protection devices were used in 145/148 of CAS cases, and self-expanding stents were used in all cases. Evaluated end points included major cardiovascular events, and a composite of death, stroke, or myocardial infarction for the duration of the follow-up. Mean follow-up was 18 months for CAS and 23 months for CEA. Significant differences were present in patient age (CAS, 75 ± 11.0 years vs CEA, 71 ± 9 years, P = 0.012), however, there were no significant differences (P = NS) in gender or smoking history. The mean modified Goldman Score was significantly higher for CAS (21.1 ± 14.8 [95% confidence interval = 18, 24]) than for CEA (6.3 ± 6.8 [95% confidence interval = 5.7, 6.9]; P = 0.0001) patients. The incidence of periprocedural complications did not vary significantly between patients treated with CAS (CVA, 1.4%; myocardial infarction [MI], 1.4%; death, 0.7%; CVA/MI/death, 3.4%) compared with CEA (CVA, 1.8%; MI, 1.1%; death, 0.4%; CVA/MI/death, 4.0%). CAS is equivalent to CEA in safety and efficacy, even when performed in patients who may be at increased surgical risk.

Get full access to this article

View all access options for this article.

References

AHA Scientific Statement.

Primary Prevention of Ischemic Stroke.

Circulation 2001; 103: 163–82.

North American Symptomatic Carotid Endarterectomy Trial Collaborators.

Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

N Engl J Med 1991; 325: 445–53.

Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.

Endarterectomy for asymptomatic carotid artery stenosis.

J Am Med Assoc 1995; 273: 1421–8.

Roubin

G.S.

, New

, Iyer

S.S.

Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: A 5-year prospective analysis.

Circulation 2001; 103: 532–8.

Faries

P.L.

, Dayal

, Clair

D.G.

Continuity in the treatment of carotid artery disease: Results of a carotid stenting program initiated by vascular surgeons.

Ann Vasc Surg 2004; 18: 669–76.

Goldman

, Caldera

D.L.

, Nussbaum

S.R.

Multifactorial index of cardiac risk in noncardiac surgical procedures.

N Engl Med 1977; 297: 845–50.

Detsky

A.S.

, Abrams

H.B.

, McLaughlin

J.R.

Predicting cardiac complications in patients undergoing non-cardiac surgery.

J Gen Intern Med 1986; 1: 211–9.

Dayal

, Kent

K.C.

Carotid endarterectomy. In: Cameron

J.L.

, ed. Current Surgical Therapy, 8th Ed. Philadelphia, PA: Mosby, 2004, pp 45–9.

Cayne

N.S.

, Faries

P.L.

, Trocciola

S.M.

Carotid angioplasty and stent-induced bradycardia and hypotension: Impact of prophylactic atropine administration and prior carotid endarterectomy.

J Vasc Surg 2005; 41: 956–61.

10.

Ramee

MAVERIC II. A prospective registry of carotid stenting with the Exponent stent and distal protection with the GuardWire in high-risk patients: 30-day results. Presented at Transcatheter Cardiovascular Therapeutics, September 27–October 1, 2004, Washington, DC.

11.

Carotid Revascularization with Endarterectomy or Stenting Systems Steering Committee.

Carotid revascularization with endarterectomy or stenting systems (CARESS): Investigator selection.

J Endovasc Ther 2001; 8: 547–9.

12.

Carotid Revascularization with Endarterectomy or Stenting Systems Steering Committee.

Carotid revascularization using end-arterectomy or stenting systems (CARESS): Phase I clinical trial.

J Endovasc Ther 2003; 10: 1021–30.

13.

Tubler

, Schluter

, Dirsch

Balloon-protected carotid artery stenting: Relationship of periprocedural neurological complications with the size of particulate debris.

Circulation 2001; 104: 2791–6.

14.

The CSSA Trial. Two-hundred patient study of carotid stenting with the Palmaz-Shatz stent for symptomatic carotid artery disease, 1998. Available at www.crf.org. Accessed January 15, 2006.

15.

Wholey

M.H.

The ARCHeR trial: Prospective clinical trial for carotid stenting in high surgical risk patients, preliminary 30-day results. Presented at the 52nd Annual Meeting of the American College of Cardiology, March 30, 2003, Chicago, IL.

16.

SHELTER. Stenting of high risk patients extracranial lesions trial with emboli removal. Available at http://www.strokecenter.org/trials. Accessed December, 15, 2005.

17.

Hopkins

L.N.

CABERNET: 30-day pivotal results. Presented at Transcatheter Cardiovascular Therapeutics, September 27–October 1, 2004, Washington, DC.

18.

White

C.J.

Beach trial: 30-day pivotal group results. Presented at 13th Annual Peripheral Angioplasty and All That Jazz, April 13–16, 2004, New Orleans, LA.

19.

Whitlow

P.L.

SECuRITY: Multicenter registry in high risk symptomatic and asymptomatic carotid disease with the Abbott Xact stent and MedNova filter. Presented at Transcatheter Cardiovascular Therapeutics, September 15–19, 2003, Washington, DC.

20.

Alberts

M.J.

Results of a multicentre prospective randomized trial of carotid artery stenting vs carotid endarterectomy.

Stroke 2001; 32: 325.

21.

Carotid and Vertebral Artery Transluminal Angioplasty Study Investigators.

Endovascular versus surgical treatment in patients with carotid stenosis in the carotid and vertebral artery trans-luminal angioplasty study (CAVATAS): A randomized trial.

Lancet 2001; 357: 1729–37.

22.

Yadav

J.S.

, Wholey

M.H.

, Kuntz

R.E.

Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients.

N Engl J Med 2004; 351: 1493–501.

23.

Ouriel

, Hertzer

N.R.

, Beven

E.G.

Preprocedural risk stratification: Identifying an appropriate population for carotid stenting.

J Vasc Surg 2001; 33: 728–32.